TXMD

TherapeuticsMD Inc

1.87

Nov 13 • 3:55 PM ET +0.05 (2.75%)

1.90

Aftermarket • 7:30 PM ET +0.03 (1.60%)

Healthcare Drug Manufacturers - Specialty & Generic USA Nano NASD

Nov 13, 4:45 PMTherapeuticsMD reports third-quarter revenue of $1.3 million and earnings of 4 cents per share

Peers: AYTU DARE RPRX LGND LPCN CPIX FEMY INVA OGN XERS

| Held by: VTI VXF BUSM DXUV DFAC DFSU DCOR

Scroll to Statements

Index	-
Market Cap	21.64M
Enterprise Value	18.01M
Income	-0.22M
Sales	3.27M
Book/sh	2.34
Cash/sh	0.79
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	1
IPO	Jan 03, 2002

P/E	-
Forward P/E	-
PEG	-
P/S	6.62
P/B	0.80
P/C	2.35
P/FCF	6.94
EV/EBITDA	-
EV/Sales	5.51
Quick Ratio	2.76
Current Ratio	2.76
Debt/Eq	0.20
LT Debt/Eq	0.17
Option/Short	Yes / Yes

EPS (ttm)	-0.02
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	83.18% 72.84%
Sales past 3/5Y	-64.91% -45.84%
EPS Y/Y TTM	52.88%
Sales Y/Y TTM	27.78%
EPS Q/Q	-72.06%
Sales Q/Q	-8.72%
Earnings	Aug 11 AMC
EPS/Sales Surpr.	- -

Insider Own	8.45%
Insider Trans	0.00%
Inst Own	31.67%
Inst Trans	-0.61%
ROA	-0.78%
ROE	-1.08%
ROIC	-0.69%
Gross Margin	49.36%
Oper. Margin	-117.80%
Profit Margin	-6.64%
SMA20	3.54%
SMA50	-5.03%
SMA200	-10.28%
Trades

Shs Outstand	11.57M
Shs Float	10.60M
Short Float	0.30%
Short Ratio	1.32
Short Interest	0.03M
52W High	2.95 -36.61%
52W Low	1.43 30.77%
Volatility	4.59% 4.49%
ATR (14)	0.08
RSI (14)	51.45
Beta	0.63
Rel Volume	2.13
Avg Volume	23.66K
Volume	50,496

Perf Week	7.47%
Perf Month	-3.11%
Perf Quarter	-6.97%
Perf Half Y	-6.50%
Perf YTD	14.72%
Perf Year	15.43%
Perf 3Y	-7.20%
Perf 5Y	-94.06%
Perf 10Y	-99.43%
Recom	1.00
Target Price	5.00
Prev Close	1.82
Price	1.87
Change %	2.75%

Consensus

Strong Buy

Avg. Price Target

$5.00

Implied Upside

+167.4%

Analysts11incl. previous ratings

Rating Distribution8 Buy · 2 Hold · 1 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Aug 07, 2020	Downgrade	JJefferies	Hold → Underperform
May 19, 2020	Downgrade	JJP Morgan	Overweight → Neutral
Dec 02, 2019	Initiated	GGuggenheim	Buy
Oct 17, 2019	Initiated	HH.C. Wainwright	Buy	$7	+274.3%
Apr 30, 2019	Resumed	NNoble Capital Markets	Outperform	$13	+595.2%
Jun 15, 2018	Initiated	JJP Morgan	Overweight	$11	+488.2%
Sep 08, 2017	Initiated	MMorgan Stanley	Equal-Weight	$6	+220.9%
Jul 11, 2017	Upgrade	OOppenheimer	Perform → Outperform
May 09, 2017	Downgrade	OOppenheimer	Outperform → Perform
Nov 22, 2016	Resumed	JJefferies	Buy	$18	+862.6%
Nov 22, 2016	Initiated	OOppenheimer	Outperform
Nov 07, 2016	Resumed	GGuggenheim	Buy
Apr 04, 2016	Initiated	GGoldman	Buy	$10	+434.8%
Dec 08, 2015	Reiterated	SStifel	Buy	$10 → $14	+648.7%
Dec 08, 2015	Reiterated	JJefferies	Buy	$15 → $18	+862.6%
Sep 21, 2015	Reiterated	JJefferies	Buy	$7 → $15	+702.1%
Jun 09, 2015	Initiated	GGuggenheim	Buy
Jul 08, 2014	Initiated	FFBR Capital	Outperform	$34	+1,718.2%
Apr 17, 2014	Reiterated	NNoble Financial	Buy	$9 → $13	+595.2%
Jan 28, 2014	Reiterated	NNoble Financial	Buy	$7.25 → $9	+381.3%

Nov-13-26 04:25PM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press)
04:05PM	TherapeuticsMD Announces Third Quarter 2026 Financial Results (Business Wire)
Aug-11-26 06:27PM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press)
04:00PM	TherapeuticsMD Announces Second Quarter 2026 Financial Results (Business Wire)
May-12-26 04:51PM	TherapeuticsMD: Q1 Earnings Snapshot (Associated Press)
04:05PM	Loading…
04:05PM	TherapeuticsMD Announces First Quarter 2026 Financial Results (Business Wire)
Mar-30-26 04:05PM	TherapeuticsMD Announces Full Year 2025 Financial Results (Business Wire) -5.24%
Nov-12-25 06:04PM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces Third Quarter 2025 Financial Results (Business Wire)
Aug-12-25 04:47PM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces Second Quarter 2025 Financial Results (Business Wire)
May-13-25 05:02PM	TherapeuticsMD: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces First Quarter 2025 Financial Results (Business Wire)
Mar-27-25 04:05PM	TherapeuticsMD Announces Full Year 2024 Financial Results (Business Wire) -6.48%
Nov-12-24 04:32PM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	TherapeuticsMD Announces Third Quarter 2024 Financial Results (Business Wire)
Aug-12-24 05:26PM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces Second Quarter 2024 Financial Results (Business Wire)
Jun-28-24 11:52AM	TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023 (InvestorPlace) -7.47%
May-10-24 08:53PM	TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024 (InvestorPlace)
04:43PM	TherapeuticsMD: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces First Quarter 2024 Financial Results (Business Wire)
Mar-29-24 04:00PM	TherapeuticsMD Announces Full Year 2023 Financial Results (Business Wire)
Mar-12-24 11:40AM	25 Countries With Highest Abortion Rates (Insider Monkey) +6.95%
Jan-30-24 11:20PM	12 Best Prenatal Vitamins For Pregnant Women (Insider Monkey)
Nov-15-23 05:08AM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press Finance) +17.41%
Nov-14-23 04:05PM	TherapeuticsMD Announces Third Quarter 2023 Financial Results (Business Wire)
Aug-14-23 07:52AM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press Finance)
06:50AM	TherapeuticsMD Announces Second Quarter 2023 Financial Results (Business Wire)
May-15-23 05:56PM	TherapeuticsMD: Q1 Earnings Snapshot (AP Finance)
04:05PM	Loading…
04:05PM	TherapeuticsMD Announces First Quarter 2023 Financial Results (Business Wire)
Apr-14-23 12:00PM	All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy (Zacks)
Apr-07-23 04:01PM	TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition (Business Wire)
Jan-03-23 06:50AM	TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma (Business Wire) +11.81%
Dec-08-22 10:42AM	Boca pharma company will cut 212 employees after failed buyout (American City Business Journals)
Dec-04-22 06:00PM	TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma (Business Wire)
Nov-14-22 07:55PM	TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -7.45% -8.20%
04:05PM	TherapeuticsMD Announces Third Quarter 2022 Financial Results (Business Wire)
Oct-31-22 06:50AM	TherapeuticsMD Announces Additional $7 Million Private Placement (Business Wire) +6.21%
Oct-03-22 01:45PM	TherapeuticsMD receives $7M investment after merger plans unravel (American City Business Journals) -7.53%
06:50AM	TherapeuticsMD Announces $7 Million Private Placement (Business Wire)
Sep-12-22 06:50AM	TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers (Business Wire) +5.55%
Aug-15-22 01:00PM	TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript (Motley Fool)
08:05AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:50AM	TherapeuticsMD Announces Second Quarter 2022 Financial Results (Business Wire)
Aug-08-22 06:50AM	TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-01-22 01:00PM	Pharma firm receives $15M investment after canceled merger (American City Business Journals) +36.60%
06:50AM	TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital (Business Wire)
Jul-15-22 01:34PM	HC Wainwright Rating & Price Target On TherapeuticsMD Under Review On 'Unclear Path' (Benzinga) +12.50%
Jul-13-22 09:48AM	Why TherapeuticsMD Shares Are Sinking Today? (Benzinga) -35.55%
08:25AM	TherapeuticsMD's stock falls 41% after tender offer expires (MarketWatch)
06:50AM	TherapeuticsMD Announces Expiration of Tender Offer (Business Wire)
Jul-06-22 06:09AM	EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer (PR Newswire)
Jun-06-22 04:05PM	EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD (PR Newswire)
May-31-22 06:00AM	TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD (Business Wire) +364.02%
May-20-22 10:52AM	Why TherapeuticsMD Shares Are Trading Higher Today (Benzinga) +36.56%
09:43AM	TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA® (Business Wire)
May-16-22 08:00PM	TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call Transcript (Motley Fool) -14.01%
05:45PM	TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	TherapeuticsMD Announces First Quarter 2022 Financial Results (Business Wire)
May-12-22 05:25PM	Harpoon Therapeutics, Inc. (HARP) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -13.87%
May-10-22 04:05PM	TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022 (Business Wire) -24.78%
Apr-14-22 04:15PM	TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million (Business Wire)
Mar-10-22 01:30PM	TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call Transcript (Motley Fool) -27.50%
08:05AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:50AM	TherapeuticsMD Announces Fourth Quarter 2021 Financial Results (Business Wire)
Mar-07-22 12:57PM	TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal (Benzinga) +43.05%
07:40AM	TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx (Business Wire)
Mar-01-22 04:30PM	TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022 (Business Wire) -5.69%
Feb-28-22 05:35PM	Nektar Therapeutics (NKTR) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +8.28%
Feb-24-22 09:05AM	Radius Health (RDUS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Jan-25-22 08:52AM	TherapeuticsMD, Inc. (NASDAQ:TXMD): Is Breakeven Near? (Simply Wall St.)
Jan-06-22 07:29AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jan-04-22 06:20AM	FDA Approves TherapeuticsMD's Low Dose Bijuva (Benzinga) +11.18%
Dec-28-21 09:53AM	Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options (Zacks)
Dec-13-21 06:08AM	TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits (Benzinga) -11.51%
Dec-10-21 04:30PM	U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA® (Business Wire)
Dec-08-21 06:50AM	TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) Allowing for a May 25, 2032 Generic Entry Date (Business Wire)
Nov-24-21 07:54AM	TherapeuticsMD (NASDAQ:TXMD) investors are sitting on a loss of 90% if they invested five years ago (Simply Wall St.)
Nov-22-21 10:40AM	Therapeuticsmd Insider Trades $580K In Company Stock (Benzinga)
Nov-12-21 03:00AM	TherapeuticsMD, Inc. (TXMD) Q3 2021 Earnings Call Transcript (Motley Fool)
Nov-11-21 06:50AM	TherapeuticsMD Announces Third Quarter 2021 Financial Results (Business Wire) -7.82%
06:45AM	TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh ODowd, as Chief Executive Officer (Business Wire)
Nov-04-21 03:01PM	TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-27-21 05:00PM	TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021 (Business Wire)
Oct-15-21 05:33PM	TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer (Business Wire)
Oct-05-21 01:28PM	What Type Of Shareholders Own The Most Number of TherapeuticsMD, Inc. (NASDAQ:TXMD) Shares? (Simply Wall St.)
Oct-04-21 09:20AM	Where Do Hedge Funds Stand On TherapeuticsMD Inc (TXMD)? (Insider Monkey)
Sep-02-21 06:50AM	Therapeutics MD Is Urging Women to Take Pause During Menopause Awareness Month (Business Wire) +7.71%
Aug-23-21 06:50AM	TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector (Business Wire) +7.12%
Aug-19-21 08:01AM	5 Penny Stocks Insiders Are Buying (Benzinga) +5.53%
Aug-09-21 04:30PM	TherapeuticsMD Announces Appointment of Hugh ODowd as President (Business Wire)
Aug-04-21 08:05AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.66%
06:50AM	TherapeuticsMD Announces Second Quarter 2021 Financial Results (Business Wire)
Jul-28-21 03:03PM	Will TherapeuticsMD (TXMD) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-26-21 06:50AM	TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 (Business Wire)
Jul-06-21 11:49AM	10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman (Insider Monkey)
Jun-29-21 08:58AM	Breakeven On The Horizon For TherapeuticsMD, Inc. (NASDAQ:TXMD) (Simply Wall St.)
May-25-21 06:50AM	TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA (Business Wire)
May-24-21 07:00AM	The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award (Business Wire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thompson Tommy G	Director	Dec 23 '25	Buy	1.67	8,400	14,031	23,179	Dec 29 04:23 PM

TherapeuticsMD, Inc. operates as a pharmaceutical company. The firm engages in licensing pharmaceutical products and collecting royalties. Its brands include BIJUVA, IMVEXXY, and ANNOVERA. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

Chief Executive OfficerMr. Marlan D. Walker J.D.

Principal Financial & Accounting OfficerMr. Joseph A. Ziegler

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

TXMD

TherapeuticsMD Inc

Upgrade your Finviz experience

All the Features.
Half the Price.